Management of Septal Perforation
Septal perforation management should begin with conservative medical therapy for symptom control, reserving surgical repair for symptomatic patients with perforations <3 cm who have failed medical management, while larger or complex perforations may benefit from customized septal prostheses.
Initial Conservative Management
Start with medical interventions to control symptoms and prevent progression:
- Emollient application (saline gels, petroleum-based ointments) to prevent crusting and bleeding
- Nasal saline irrigation to maintain mucosal hydration
- Humidification of the environment
- Avoidance of nasal trauma (no picking, rubbing, or digital manipulation)
These measures are low-cost, noninvasive, and well-tolerated with minimal risks beyond possible bleeding during application 1.
Patient Selection for Surgical Intervention
Critical factors determining surgical candidacy:
Perforation size: Best outcomes with perforations <2-3 cm diameter
Mucosal health: Adequate surrounding healthy mucosa is essential for flap elevation and healing 3, 4
Osteo-cartilaginous support: Sufficient septal framework prevents mucosal adhesion and supports repair 4, 5
Symptom burden: Persistent nasal obstruction, crusting, bleeding, or whistling despite medical management
Systemic health: Absence of active inflammatory disease (granulomatosis with polyangiitis, sarcoidosis) and adequate healing capacity 3, 6
Surgical Approach Selection
The choice between endonasal versus open approaches shows equivalent outcomes (91% overall closure rate), with no significant difference in success rates 7. Selection should be based on:
For Small-to-Medium Perforations (<2 cm, anterior location):
- Endonasal bilateral mucosal flap repair with interposition graft
- Unilateral inverted mucosal flap technique for perforations <2 cm with thick surrounding mucosa 5
- Success rates: 70-82% for perforations up to 3 cm 2
For Larger Perforations (>2 cm) or Poor Surgical Candidates:
- 3D-printed customized septal prosthesis (button) provides meaningful symptom relief without surgical risks 8, 9
- Well-tolerated with significant quality of life improvement 9
- Particularly useful in patients with comorbidities (high ASA scores) or hereditary hemorrhagic telangiectasia 9
Technical Considerations:
- Bilateral flaps versus unilateral: No outcome difference, but bilateral provides better coverage 7
- Interposition grafts (porcine collagen, cartilage): Widely used but not statistically superior 7, 2
- Splinting: Internal splints recommended; nasal packing role less clear but increasingly favoring absorbable materials (NasoPore) over BIPP 3
Critical Perioperative Management
Timing of intervention:
- Delay surgery until any active inflammatory process is controlled 3, 6
- Ensure adequate mucosal healing time after trauma or previous surgery
Postoperative care:
- Intranasal splints for 2-4 weeks 3
- Prophylactic antibiotics remain controversial; consider based on individual risk 3
- Aggressive nasal hygiene with saline irrigation
- Follow-up at 12+ months to assess long-term closure 3, 10
Common Pitfalls to Avoid
⚠️ Bilateral cautery during epistaxis treatment: The guideline explicitly warns that bilateral cautery should be used "selectively and cautiously to minimize the risk of septal perforation" 1. This is a preventable iatrogenic cause.
⚠️ Operating on perforations >3 cm without realistic expectations: Success rates drop dramatically; consider prosthetic options first 2.
⚠️ Inadequate assessment of mucosal quality: Thin, scarred, or inflamed mucosa predicts failure 4, 5.
⚠️ Insufficient follow-up duration: Minimum 12 months needed to assess true surgical success 10.
Outcome Expectations
Even when complete closure is not achieved, 81-91% of patients report being asymptomatic after intervention for perforations up to 3 cm 2. Both surgical repair and prosthetic devices demonstrate significant improvement in validated symptom scores (NOSE-Perf scale), though surgical repair shows greater symptom reduction when successful 8.